Dr Jay B Gordon, PHD | |
1683 Route 88, Brick, NJ 08724 | |
(732) 840-5266 | |
(732) 840-7840 |
Full Name | Dr Jay B Gordon |
---|---|
Gender | Male |
Speciality | Clinical Psychologist |
Experience | 30 Years |
Location | 1683 Route 88, Brick, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255439014 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | 375900 (New Jersey) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pathways Neuropsychology Associates | 6002104692 | 8 |
News Archive
Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.
Researchers at Ohio State University gave a battery of simple cognitive tests to 19 first-year medical students one to two days before a regular classroom exam – a period when they would be highly stressed. Students were also given a similar battery of tests a week after the exam, when things were less hectic.
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease.
The E484K mutation has also been found on the B.1.351 and P.1 variant, contributing to their status as variants of concern. In February 2021, Public Health England published a report of 11 B.1.1.7 genomes that also had the E484K spike mutation. Currently, there are 247 isolates of B.1.1.7 + E484K reported globally, and new research finds the first reports of it in southeastern Pennsylvania.
› Verified 8 days ago
Entity Name | Pathways Neuropsychology Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619421625 PECOS PAC ID: 6002104692 Enrollment ID: O20161014000419 |
News Archive
Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.
Researchers at Ohio State University gave a battery of simple cognitive tests to 19 first-year medical students one to two days before a regular classroom exam – a period when they would be highly stressed. Students were also given a similar battery of tests a week after the exam, when things were less hectic.
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease.
The E484K mutation has also been found on the B.1.351 and P.1 variant, contributing to their status as variants of concern. In February 2021, Public Health England published a report of 11 B.1.1.7 genomes that also had the E484K spike mutation. Currently, there are 247 isolates of B.1.1.7 + E484K reported globally, and new research finds the first reports of it in southeastern Pennsylvania.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jay B Gordon, PHD 1683 Route 88, Brick, NJ 08724 Ph: (732) 840-5266 | Dr Jay B Gordon, PHD 1683 Route 88, Brick, NJ 08724 Ph: (732) 840-5266 |
News Archive
Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.
Researchers at Ohio State University gave a battery of simple cognitive tests to 19 first-year medical students one to two days before a regular classroom exam – a period when they would be highly stressed. Students were also given a similar battery of tests a week after the exam, when things were less hectic.
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease.
The E484K mutation has also been found on the B.1.351 and P.1 variant, contributing to their status as variants of concern. In February 2021, Public Health England published a report of 11 B.1.1.7 genomes that also had the E484K spike mutation. Currently, there are 247 isolates of B.1.1.7 + E484K reported globally, and new research finds the first reports of it in southeastern Pennsylvania.
› Verified 8 days ago
Dr. George William Mcdermott, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 115 Princeton Ave, Brick, NJ 08724 Phone: 732-458-6748 | |
Alyssa Marie Cocchiarella, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 711 Marys Dr, Brick, NJ 08723 Phone: 732-288-5696 | |
Dr. Justine Fulton, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 445 Brick Blvd Ste 302, Brick, NJ 08723 Phone: 908-415-6354 | |
Carole M Beyer, ED D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1683 Route 88, Brick, NJ 08724 Phone: 732-840-5266 Fax: 732-840-7840 | |
Dr. Adam David Christmann, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1683 Route 88 W Ste A, Brick, NJ 08724 Phone: 732-840-5266 | |
Nicholas Nestor Perez, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1683 Nj-88, Brick, NJ 08724 Phone: 732-840-5266 |